Midnight MarketsV1.0
⚠ Not financial adviceNot financial advice. Independent research, not investment recommendations. The author and website make no representation as to accuracy or completeness. Do your own due diligence before acting on anything you read here. Read the full disclaimer →
The Bioprocessing Single-Use — Filters, Resins & Bioreactors · The GLP-1 & Bio Supply Chain — Peptides, Bioprocessing & Diagnostics

RGEN

Repligen
loading…
History0 bars

Filtration, chromatography, and analytics for every biologics manufacturer. Recovery from 2024 destocking now underway.

What they do

Makes filtration, chromatography resins, and process analytics for biologics manufacturers. Q1 2026 revenue $194M (+15%); adjusted EPS $0.48 vs $0.38 estimate. Recovery from the 2024 destocking is now clearly underway.